source
- AI startup Chai Discovery inks GSK deal to develop biologics using artificial intelligenceChai Discovery, an artificial‑intelligence focused biotech, has signed a collaboration agreement with GlaxoSmithKline to create biologic medicines using its AI platform. The partnership will lever…
- GSK partners with Chai Discovery to use AI protein-folding models after successful wet-lab testsGSK has entered a collaboration with Chai Discovery, a biotech firm that offers AI‑driven protein folding and design tools. The agreement gives GSK access to Chai's models, which were reported to…